Corindus Vascular Robotics Inc (NYSEAMERICAN:CVRS) was the recipient of a significant growth in short interest during the month of November. As of November 30th, there was short interest totalling 11,390,423 shares, a growth of 11.2% from the November 15th total of 10,240,051 shares. Approximately 12.4% of the company’s stock are short sold. Based on an average daily volume of 975,311 shares, the short-interest ratio is currently 11.7 days.

Corindus Vascular Robotics (CVRS) traded down $0.07 during trading hours on Monday, reaching $1.15. The company’s stock had a trading volume of 430,907 shares, compared to its average volume of 719,792. Corindus Vascular Robotics has a 52 week low of $0.40 and a 52 week high of $2.25.

Corindus Vascular Robotics (NYSEAMERICAN:CVRS) last released its earnings results on Tuesday, November 7th. The medical equipment provider reported ($0.04) EPS for the quarter, topping analysts’ consensus estimates of ($0.05) by $0.01. Corindus Vascular Robotics had a negative return on equity of 110.93% and a negative net margin of 323.84%. The company had revenue of $2.43 million for the quarter, compared to the consensus estimate of $3.60 million.

Large investors have recently added to or reduced their stakes in the business. Bank of New York Mellon Corp lifted its holdings in Corindus Vascular Robotics by 40.7% during the 2nd quarter. Bank of New York Mellon Corp now owns 229,380 shares of the medical equipment provider’s stock worth $426,000 after buying an additional 66,368 shares during the last quarter. Essex Investment Management Co. LLC acquired a new stake in shares of Corindus Vascular Robotics during the 3rd quarter worth approximately $1,213,000. Teachers Advisors LLC raised its position in shares of Corindus Vascular Robotics by 184.7% during the 2nd quarter. Teachers Advisors LLC now owns 167,633 shares of the medical equipment provider’s stock worth $312,000 after purchasing an additional 108,745 shares during the period. Vanguard Group Inc. raised its position in shares of Corindus Vascular Robotics by 57.6% during the 2nd quarter. Vanguard Group Inc. now owns 3,279,185 shares of the medical equipment provider’s stock worth $6,100,000 after purchasing an additional 1,198,384 shares during the period. Finally, Northern Trust Corp raised its position in shares of Corindus Vascular Robotics by 42.4% during the 2nd quarter. Northern Trust Corp now owns 959,920 shares of the medical equipment provider’s stock worth $1,786,000 after purchasing an additional 285,811 shares during the period.

A number of research analysts have commented on the company. BidaskClub downgraded Corindus Vascular Robotics from a “hold” rating to a “sell” rating in a report on Wednesday, August 16th. Zacks Investment Research raised Corindus Vascular Robotics from a “hold” rating to a “buy” rating and set a $1.75 target price on the stock in a report on Wednesday, August 23rd. Finally, ValuEngine raised Corindus Vascular Robotics from a “sell” rating to a “hold” rating in a report on Wednesday, August 23rd. Two investment analysts have rated the stock with a sell rating and three have assigned a buy rating to the company. The company presently has a consensus rating of “Hold” and an average price target of $2.33.

ILLEGAL ACTIVITY NOTICE: This piece of content was originally published by American Banking News and is owned by of American Banking News. If you are accessing this piece of content on another website, it was illegally copied and republished in violation of US & international copyright & trademark laws. The original version of this piece of content can be viewed at https://www.americanbankingnews.com/2017/12/11/corindus-vascular-robotics-inc-cvrs-short-interest-update.html.

About Corindus Vascular Robotics

Corindus Vascular Robotics, Inc is engaged in robotic-assisted vascular interventions. The Company’s CorPath System is a medical device that brings robotic-assisted precision to radial, coronary and peripheral procedures. The workstation allows the physician greater control and the freedom from wearing heavy lead protective equipment that causes musculoskeletal injuries.

Receive News & Ratings for Corindus Vascular Robotics Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corindus Vascular Robotics Inc and related companies with MarketBeat.com's FREE daily email newsletter.